Celcuity, a clinical-stage company developing a cancer drug, had promising clinical trials. Among Minnesota’s public companies, half saw their stock increase this year.
Minnesota ranked fifth nationally in the number of patents per capita last year thanks to companies like Medtronic, Boston Scientific, Ecolab and Target. But one stands above.